KMID : 0366220090440040304
|
|
Korean Journal of Hematology 2009 Volume.44 No. 4 p.304 ~ p.309
|
|
Oral Beclomethasone Dipropionate for the Treatment of Steroid-refractory Gastrointestinal Acute Graft-versus-host Disease
|
|
Lee Sung-Eun
Lee Seok Cho Byung-Sik Eom Ki-Seong Kim Yoo-Jin Kim Hee-Je Min Chang-Ki Cho Seok-Goo Kim Dong-Wook Lee Jong-Wook Min Woo-Sung Park Chong-Won Kim Chun-Choo
|
|
Abstract
|
|
|
Acute graft-versus-host disease (GVHD) is one of the most severe complications following allogeneic stem cell transplantation (SCT), and involvement of the gut has been associated with increased mortality and a poorer response to high-dose systemic corticosteroids. For over a decade, oral beclomethasone dipropionate (BDP) has been studied in the treatment of acute gastrointestinal GVHD, as a monotherapy, or in combination with systemic corticosteroids. Here we report, for the first time in Korea, the efficacy of oral BDP (8 mg/day for 25 days) in 3 adults with acute lymphoblastic leukemia who developed steroid-refractory gastrointestinal GVHD (grade III) after myeloablative conditioning SCT (1 matched sibling transplant, 2 matched unrelated transplants). All patients responded completely to oral BDP treatment. Oral BDP is safe and effective for the control of steroid-refractory acute gastrointestinal GVHD. (Korean J Hematol 2009;44:304-309.)
|
|
KEYWORD
|
|
Oral beclomethasone dipropionate, Allogeneic stem cell transplantation, Gastrointestinal acute graft-versus-host disease
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|